newsfilter
← Latest News
PR Newswire·

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company advancing a pipeline of innovative...